Showing results (31-40 of 800) with videos related to
Sort By:
Pageof 80
Hematology. American Society of Hematology. Education Program|December 4, 2020
How to manage CML patients with comorbiditiesJorge CortesJournal of Hematology & Oncology|November 14, 2024
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD-positive AMLJorge CortesClinical Lymphoma|October 15, 2003
Farnesyltransferase inhibitors in acute myeloid leukemia and myelodysplastic syndromesJorge CortesCancer|June 24, 2005
Outcome of patients with acute myelogenous leukemia after second salvage therapyFrancis Giles, Susan O'Brien, Jorge Cortes, et al.Cancer|April 30, 2005
Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986Rashid Saba, Elias Jabbour, Francis Giles, et al.Cancer|September 13, 2007
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failureJorge Cortes, Alfonso Quintás-Cardama, Guillermo Garcia-Manero, et al.Cancer|June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicityElias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.Leukemia & Lymphoma|February 28, 2007
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phaseAlfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Jorge Cortes, et al.Leukemia Research|August 22, 2008
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemiaChen-Hsiung Yeh, Richard Tseng, Zhong Zhang, et al.Pageof 80